SCHEMBL5319019

SCHEMBL5319019

[CH2]c1ccc(Br)c(Br)c1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA4 P22748 2/20 0.40
CA6 P23280 2/20 0.40
TDP1 Q9NUW8 2/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
RECQL P46063 2/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
APEX1 P27695 1/20 0.32
BLM P54132 1/20 0.32
KMT2A Q03164 1/20 0.32
CYP3A4 P08684 1/20 0.32
TSHR P16473 1/20 0.32
ALOX15 P16050 2/20 0.32
MAPK1 P28482 1/20 0.32
HIF1A Q16665 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL581815 0.77 CA1 (0.48) CA1CA2CA4CA6TDP1
SCHEMBL153459 0.75 TDP1 (0.32) TDP1
SCHEMBL16431772 0.72 CA1 (0.43) CA1CA2CA4CA6TDP1
SCHEMBL69425 0.72 CA1 (0.43) CA1CA2CA4CA6TDP1
SCHEMBL15094360 0.70 MAPT (0.32) TDP1ALDH1A1HPGDRECQLKDM4E
SCHEMBL9579656 0.69 CA1 (0.36) CA1CA2CA4CA6
SCHEMBL6960971 0.68 CA1 (0.40) CA1CA2CA4CA6TDP1
SCHEMBL21616742 0.68 ALDH1A1 (0.31) ALDH1A1
SCHEMBL22657869 0.68 PTPN1 (0.36) CA1CA2CA4CA6TDP1
SCHEMBL10736045 0.68 GAA (0.32) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2274205-A None JP disclosed
CN-106474051-B Reverse temperature-sensitive reversible hydrogel composition 博任达生化科技(上海)有限公司 2022-07-08 CN disclosed
CN-106511259-B Reverse temperature-sensitive reversible hydrogel composition 博任达生化科技(上海)有限公司 2020-03-20 CN disclosed
WO-2007101062-A1 ANTIMICROBIAL INSERT DEVICE FOR WATER-BEARING APPLIANCE MICROBAN PRODUCTS COMPANY (US) 2007-09-07 WO disclosed
WO-2007076413-A2 ANTIMICROBIAL DURABLE MEDICAL EQUIPMENT MICROBAN PRODUCTS COMPANY (US) 2007-07-05 WO disclosed
US-20070110781-A1 ANTIMICROBIAL ARTICLE FOR USE IN MEDICAL ENVIRONMENT MICROBAN PRODUCTS COMPANY (US) 2007-05-17 US disclosed
US-6939554-B2 Antimicrobial polymer MICHIGAN BIOTECHNOLOGY INSTITUTE (US) 2005-09-06 US disclosed
US-6821943-B2 MIXTURE OF ANTISEPTIC AND POLYETHERSILOXANE COPOLYMER S. C. JOHNSON & SON, INC. 2004-11-23 US disclosed
US-20030157193-A1 Crosslinked chemical combination of a polymer having amino group-containing side chains along a backbone forming the polymer, an antimicrobial agent selected from quaternary ammonium compounds, gentian violet compounds, iodine compounds MICHIGAN BIOTECHNOLOGY INSTITUTE 2003-08-21 US disclosed
WO-2003066721-A1 ANTIMICROBIAL POLYMER MICHIGAN BIOTECHNOLOGY INSTITUTE (US) 2003-08-14 WO disclosed
JP-H02274205-A BRUSH OR THE LIKE IPPOSHA OIL IND CO LTD 1990-11-08 JP disclosed
EP-0356481-A4 PURIFIED HEMOGLOBIN SOLUTIONS AND METHOD FOR MAKING SAME. BAXTER INT (US) 1990-06-05 EP disclosed
EP-0356481-A1 PURIFIED HEMOGLOBIN SOLUTIONS AND METHOD FOR MAKING SAME. BAXTER INT (US) 1990-03-07 EP disclosed
WO-1989006969-A1 PURIFIED HEMOGLOBIN SOLUTIONS AND METHOD FOR MAKING SAME BAXTER INTERNATIONAL INC. (US) 1989-08-10 WO disclosed
US-4357476-A Nonylamines CIBA GEIGY CORPORATION, N.Y. (US) 1982-11-02 US disclosed
US-4336270-A BACTERICIDES, FUNGICIDES CIBA-GEIGY CORPORATION (US) 1982-06-22 US disclosed
US-4160833-A ANIMAL FEED ADDITIVE AND MICROBIOCIDE CIBA-GEIGY CORPORATION (US) 1979-07-10 US disclosed
US-4139560-A Nonylamines CIBA GEIGY CORPORATION (US) 1979-02-13 US disclosed
US-3991124-A FOR CONTROLLING MICROORGANISMS AND HELMINTHS CIBA-GEIGY CORPORATION (US) 1976-11-09 US disclosed
US-3956402-A MICROBIOCIDES CIBA-GEIGY CORPORATION (US) 1976-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030157193-A1 Crosslinked chemical combination of a polymer having amino group-containing side chains along a backbone forming the polymer, an antimicrobial agent selected from quaternary ammonium compounds, gentian violet compounds, iodine compounds POLL, PCNA, TYMP CA1 1310/4885CA2 1042/4885CA4 285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.